These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30566041)

  • 1. Bone Marrow-Derived Proangiogenic Cells Mediate Pulmonary Arteriole Stiffening via Serotonin 2B Receptor Dependent Mechanism.
    Bloodworth NC; Clark CR; West JD; Snider JC; Gaskill C; Shay S; Scott C; Bastarache J; Gladson S; Moore C; D'Amico R; Brittain EL; Tanjore H; Blackwell TS; Majka SM; Merryman WD
    Circ Res; 2018 Dec; 123(12):e51-e64. PubMed ID: 30566041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension.
    Launay JM; Hervé P; Callebert J; Mallat Z; Collet C; Doly S; Belmer A; Diaz SL; Hatia S; Côté F; Humbert M; Maroteaux L
    Blood; 2012 Feb; 119(7):1772-80. PubMed ID: 22186990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation.
    Sahara M; Sata M; Morita T; Nakamura K; Hirata Y; Nagai R
    Circulation; 2007 Jan; 115(4):509-17. PubMed ID: 17242277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension.
    Hayashida K; Fujita J; Miyake Y; Kawada H; Ando K; Ogawa S; Fukuda K
    Chest; 2005 May; 127(5):1793-8. PubMed ID: 15888860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species induced Ca
    Suresh K; Servinsky L; Jiang H; Bigham Z; Yun X; Kliment C; Huetsch J; Damarla M; Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L893-L907. PubMed ID: 29388466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model.
    Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Cheng Y; Goldberg L; Ventetuolo CE; Liang O; Klinger JR; Quesenberry PJ
    Stem Cells Transl Med; 2017 Jul; 6(7):1595-1606. PubMed ID: 28474513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Zopf DA; das Neves LA; Nikula KJ; Huang J; Senese PB; Gralinski MR
    Eur J Pharmacol; 2011 Nov; 670(1):195-203. PubMed ID: 21914448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation.
    Ikutomi M; Sahara M; Nakajima T; Minami Y; Morita T; Hirata Y; Komuro I; Nakamura F; Sata M
    J Mol Cell Cardiol; 2015 Sep; 86():121-35. PubMed ID: 26231083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice.
    Raoul W; Wagner-Ballon O; Saber G; Hulin A; Marcos E; Giraudier S; Vainchenker W; Adnot S; Eddahibi S; Maitre B
    Respir Res; 2007 Jan; 8(1):8. PubMed ID: 17263874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 5-HT
    Ayme-Dietrich E; Lawson R; Côté F; de Tapia C; Da Silva S; Ebel C; Hechler B; Gachet C; Guyonnet J; Rouillard H; Stoltz J; Quentin E; Banas S; Daubeuf F; Frossard N; Gasser B; Mazzucotelli JP; Hermine O; Maroteaux L; Monassier L
    Br J Pharmacol; 2017 Nov; 174(22):4123-4139. PubMed ID: 28806488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension.
    Yan L; Chen X; Talati M; Nunley BW; Gladson S; Blackwell T; Cogan J; Austin E; Wheeler F; Loyd J; West J; Hamid R
    Am J Respir Crit Care Med; 2016 Apr; 193(8):898-909. PubMed ID: 26651104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model.
    Peloquin GL; Johnston L; Damarla M; Damico RL; Hassoun PM; Kolb TM
    Respir Res; 2019 Jun; 20(1):123. PubMed ID: 31208454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β1 signaling and Krüppel-like factor 10 regulate bone marrow-derived proangiogenic cell differentiation, function, and neovascularization.
    Wara AK; Foo S; Croce K; Sun X; Icli B; Tesmenitsky Y; Esen F; Lee JS; Subramaniam M; Spelsberg TC; Lev EI; Leshem-Lev D; Pande RL; Creager MA; Rosenzweig A; Feinberg MW
    Blood; 2011 Dec; 118(24):6450-60. PubMed ID: 21828131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting 5-HT
    Snider JC; Riley LA; Mallory NT; Bersi MR; Umbarkar P; Gautam R; Zhang Q; Mahadevan-Jansen A; Hatzopoulos AK; Maroteaux L; Lal H; Merryman WD
    Circulation; 2021 Mar; 143(13):1317-1330. PubMed ID: 33474971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension.
    Yu YA; Malakhau Y; Yu CA; Phelan SJ; Cumming RI; Kan MJ; Mao L; Rajagopal S; Piantadosi CA; Gunn MD
    J Immunol; 2020 Mar; 204(6):1474-1485. PubMed ID: 31996456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary arterial hypertension, bone marrow, endothelial cell precursors and serotonin].
    Ayme-Dietrich E; Banas SM; Monassier L; Maroteaux L
    Biol Aujourdhui; 2016; 210(2):79-88. PubMed ID: 27687599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation.
    Yoshida H; Kitaichi T; Urata M; Kurobe H; Kanbara T; Motoki T; Kitagawa T
    Ann Thorac Surg; 2009 Aug; 88(2):418-24. PubMed ID: 19632386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lineage Tracing Reveals the Dynamic Contribution of Pericytes to the Blood Vessel Remodeling in Pulmonary Hypertension.
    Bordenave J; Tu L; Berrebeh N; Thuillet R; Cumont A; Le Vely B; Fadel E; Nadaud S; Savale L; Humbert M; Huertas A; Guignabert C
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):766-782. PubMed ID: 31969018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.